Intelence and Gingival pain - a phase IV clinical study of FDA data

Summary:

Gingival pain is reported as a side effect among people who take Intelence (etravirine), especially for people who are male, also take Coumadin,.

The phase IV clinical study analyzes which people have Gingival pain when taking Intelence. It is created by eHealthMe based on reports of 3,739 people who have side effects when taking Intelence from the FDA, and is updated regularly.

What is Intelence?

Intelence has active ingredients of etravirine. It is often used in hiv infection. eHealthMe is studying from 3,797 Intelence users. Check the latest studies of Intelence.

What is Gingival pain?

Gingival pain (gum pain) is found to be associated with 900 drugs and 811 conditions by eHealthMe. Check the latest studies of Gingival pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

3,739 people reported to have side effects when taking Intelence.
Among them, 14 people (0.37%) have Gingival pain.

Among these 14 people:

What is the gender of people who have Gingival pain when taking Intelence? *

female: 7.14 %
male: 92.86 %

What are other drugs people take besides Intelence? *

What are other side effects people have besides Gingival pain? *

Kidney Stones: 14 people, 100.00%
Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 14 people, 100.00%
Osteonecrosis Of Jaw (death of bone of jaw): 14 people, 100.00%
Diarrhea: 14 people, 100.00%
Neuropathy Peripheral (surface nerve damage): 14 people, 100.00%
Ear Barotrauma (discomfort and possible damage in the ear due to pressure differences between the inside and outside of the eardrum): 14 people, 100.00%
Ear Discomfort: 14 people, 100.00%
Ear Pain: 14 people, 100.00%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 14 people, 100.00%
Facial Pain: 14 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Intelence and have Gingival pain?

- Check whether Gingival pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Intelence:

Intelence (3,797 reports)

Gingival pain treatments and more:

Gingival pain (9,837 reports)

Browse all side effects of Intelence:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gingival pain:

Gingival pain (900 drugs)

Browse all the conditions that are associated with Gingival pain:

Gingival pain (811 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etravirine (the active ingredients of Intelence) and Intelence (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.